Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Epioxa Hd/Epioxa Kit

(Riboflavin 5'-Phosphate)

Small molecule

GGlaukos Corporation

0

Indications

2

Total Trials

0

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

Clinical

Trials by Indication[1]

Keratoconus2 trials

Epi-On Corneal Crosslinking for Keratoconus

Completed·CComprehensive EyeCare of Central Ohio·Phase 4·NCT03245853·20 enrolled

Treatment of Keratoconus Using Collagen Cross-Linking

Unknown status·UUniversity at Buffalo·Phase 2/3·NCT00841386·150 enrolled

Regulatory

FDA Approval Timeline[3]

Apr 15, 2016

PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA

NDA NDA203324

Oct 17, 2025

EPIOXA HD/EPIOXA KIT

NDA NDA219910

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Riboflavin 5'-Phosphate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Riboflavin 5'-Phosphate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
OpenFDA — FDA approval records (NDA NDA219910). U.S. Food & Drug Administration.
[4]
SEC EDGAR — Glaukos Corporation company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: GGlaukos Corporation

Related News